Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05701098 · ClinicalTrials.gov registry record · NA

SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)

A NA study of Kidney Stone and Nephrolithiasis, sponsored by SonoMotion.

Active
Registry status
NA
Development phase
116
Enrollment target
10
Study locations

NCT05701098 is a NA study of Kidney Stone and Nephrolithiasis that is active but no longer recruiting, run by SonoMotion. The registered enrollment target is 116 participants, below the 189-participant average among 28 other Kidney Stone trials with a reported enrollment target (39% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05701098, a NA study of Kidney Stone and Nephrolithiasis, is active but no longer recruiting, sponsored by SonoMotion.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
116 participants
Enrollment target
10
Study locations

Study Summary

The goal of this clinical trial is to test the Break Wave™ system in patients with upper urinary tract stones. The main question it aims to answer is whether the device is safe and effective in fragmenting (breaking) stones. Participants will a) undergo the Break Wave™ procedure, b) have a telehealth visit at 2 weeks, and c) return for an imaging study at approximately 10 weeks post-procedure.

Conditions Studied

Kidney Stone Nephrolithiasis Urolithiasis Kidney Calculi Renal Calculi Urinary Calculi Nephrolith

Interventions

  • DEVICE Break Wave extracorporeal lithotripsy

Study Locations (10)

California

  • University of California- San Diego - San Diego
  • University of California - San Francisco - San Francisco
  • Kaiser Permanente - Santa Clara

Illinois

  • Northwestern Medicine - Chicago

Pennsylvania

  • Lehigh Valley Health Network - Allentown

Tennessee

  • Vanderbilt University - Nashville

Washington

  • University of Washington - Seattle

Alberta

  • University of Alberta - Edmonton

British Columbia

  • University of British Columbia - Vancouver

Ontario

  • St. Michael's Hospital, University of Toronto - Toronto

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2023-10-09
Est. Completion 2026-01
Phase NA

Sponsor

SonoMotion

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05701098

The ClinicalTrials.gov registry entry for NCT05701098 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 189-participant average among 28 other Kidney Stone trials with a reported enrollment target (39% lower). The listed sponsor is SonoMotion, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Kidney Stone appearing as the primary indexed condition, and to 1 intervention - of which Break Wave extracorporeal lithotripsy is the first listed.

NCT05701098 reports 10 study locations spanning 8 distinct geographic areas - top geographies include California, Illinois, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05701098 about?

NCT05701098 is a clinical study titled "SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)". The goal of this clinical trial is to test the Break Wave™ system in patients with upper urinary tract stones. The main question it aims to answer is whether the device is safe and effective in fragmenting (breaking) stones. Participants will a) undergo the Break Wave™ procedure, b) have a teleheal...

What is the current status of trial NCT05701098?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2023-10-09. Estimated completion is 2026-01.

What conditions does trial NCT05701098 study?

This clinical trial studies the following conditions: Kidney Stone, Nephrolithiasis, Urolithiasis, Kidney Calculi, Renal Calculi.

What interventions are being tested in trial NCT05701098?

The interventions under investigation include: Break Wave extracorporeal lithotripsy (DEVICE).

Who is sponsoring clinical trial NCT05701098?

This trial is sponsored by SonoMotion, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05701098 being conducted?

This trial has 10 study locations across California, Illinois, Pennsylvania, Tennessee, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Stone

All registered trials for this condition

Nephrolithiasis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.